Clinical Trial

Hemorrhage Clinical Trial 20223022

[LCID Study Number: 20223022]

Nebulized Tranexamic Acid Given Prior To Transbronchial Biopsy For The Prevention Of Procedure Related Hemorrhage: A Pilot Study

The purpose of this pilot study is to determine whether nebulized tranexamic acid (TXA) prior to performance of transbronchial lung biopsy will decrease the degree of biopsyrelated hemorrhage.

Disease/Condition: Hemorrhage

Department: Pulmonary and Critical Care Medicine

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact Email:

Clinical Trial Details

Protocol #: 20223022

Principal Investigator(s): Carla R Lamb

Study Coordinator(s): Melissa Dunbar

Trial Phase: Investigator Initiated Study Phase 4